Mānuka Honey for Burns: A Review of the Clinical Evidence

Topical honey for minor burns has been studied in randomized controlled trials since the early 1990s. This article reviews the published evidence on Mānuka honey for burn treatment and the important caveats around retail-grade jars.

What the clinical evidence shows

The earliest randomized trial in this space (Subrahmanyam, 1991) compared honey-impregnated gauze with conventional silver sulfadiazine on partial-thickness burns and found shorter healing times in the honey group. A second trial by the same investigator (Subrahmanyam, 1993) compared honey gauze with polyurethane film (OpSite) and reported similar results.

A 2009 systematic review and meta-analysis (Wijesinghe et al., NZ Medical Journal) examined 19 randomized trials of honey on burns. The pooled analysis suggested faster healing of partial-thickness burns with honey compared with conventional dressings, though the authors flagged methodological limitations in many of the included trials.

The mechanistic explanation, supported by Mavric et al. (2008), is that Mānuka honey's high methylglyoxal content provides stable antibacterial activity that survives the moist conditions of a burn wound, where peroxide-dependent honey activity would degrade.

What the evidence does not support

The published trials used either medical-grade honey products or pre-treated honey gauzes. They are not evidence that consumers should self-treat burns with a retail jar. Retail food-grade Mānuka is not sterilized and can contain bacterial spores. For any burn that breaks the skin, blisters significantly, or covers a meaningful body surface area, clinical care is indicated.

The trials that exist are mostly on partial-thickness (second-degree) burns of small surface area. Full-thickness burns and large surface burns are not within the studied population.

What this means for buyers

If you are buying Mānuka honey because of its reputation in burn care, the relevant takeaways are:

• The mechanism (MGO-driven non-peroxide antibacterial activity) is real and well-characterized.
• Sterile Mānuka-based wound dressings exist and are FDA-cleared. A retail jar is not equivalent.
• Higher-grade jars (UMF 15+ and above, MGO 514+ and above) carry more of the studied antibacterial compound. See UMF explained and our best Mānuka honey roundup for current options at higher potency tiers.

Common questions

Is Mānuka honey safer than silver sulfadiazine?

The trials did not establish a safety advantage; they established broadly comparable healing rates with somewhat different side-effect profiles. Either treatment for a burn should be selected by a clinician.

Can I put a retail jar of Mānuka on a sunburn?

The published evidence is on minor partial-thickness burns, not on sunburn specifically. A retail jar is not sterile. For sunburn pain and redness, established topical care exists.

Sources

• Subrahmanyam M. Topical application of honey in treatment of burns. British Journal of Surgery. 1991;78(4):497-8.
• Subrahmanyam M. Honey impregnated gauze versus polyurethane film (OpSite) in the treatment of burns - a prospective randomised study. British Journal of Plastic Surgery. 1993;46(4):322-3.
• Wijesinghe M, Weatherall M, Perrin K, Beasley R. Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. The New Zealand Medical Journal. 2009;122(1295):47-60.
• Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Leptospermum scoparium (Mānuka) honeys from New Zealand. Molecular Nutrition & Food Research. 2008;52(4):483-9.